REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease

Sleep

Volumn 34, Issue 8, 2011, Pages 1119-1125

  Verhave, Peternella S ^a,b   Jongsma, Marjan J ^a   Van Den Berg, Roland M ^a   Vis, José C ^c   Vanwersch, Raymond A P ^a   Smit, August B ^b   Van Someren, Eus J W ^b,d   Philippens, Ingrid H C H M ^e  

^a TNO   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c Sleepvision   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^e BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Atonia; EEG; Marmoset; Muscle tone; Parkinson's disease; REM sleep behavior disorder (RBD)

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; EYE HAND COORDINATION; FEMALE; LOCOMOTION; MALE; MOTOR ACTIVITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REM SLEEP;

ANALYSIS OF VARIANCE; ANIMALS; CALLITHRIX; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; MPTP POISONING; PARKINSON DISEASE; REM SLEEP BEHAVIOR DISORDER;

EID: 79961228775     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/SLEEP.1174     Document Type: Article

References (42)

1. Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 1993;34:710-4. (Pubitemid 23333244)
2. Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001;57:1392-6. (Pubitemid 32995718)
3. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 1992;42:1371-4.
4. Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002;59:585-9. (Pubitemid 34919994)
5. Berg D. Biomarkers for the early detection of Parkinson's and Alzheimer's disease. Neurodegener Dis 2008;5:133-6. (Pubitemid 351347830)
6. Tolosa E, Gaig C, Santamaria J, Compta Y. Diagnosis and the premotor phase of Parkinson disease. Neurology 2009;72:S12-20.
7. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998;13:895-9.
8. Oerlemans WG, de Weerd AW. The prevalence of sleep disorders in patients with Parkinson's disease. A self-reported, community-based survey. Sleep Med 2002;3:147-9. (Pubitemid 34303112)
9. van Hilten B, Hoff JI, Middelkoop HA, et al. Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch Neurol 1994;51:922-8. (Pubitemid 24286048)
10. Iranzo A, Santamaria J, Rye DB, et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology 2005;65:247-52. (Pubitemid 41022369)
11. Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006;66:845-51. (Pubitemid 43739758)
12. Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006;5:572-7. (Pubitemid 43867426)
13. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996;46:388-93.
14. Ferini-Strambi L, Zucconi M. REM sleep behavior disorder. Clin Neurophysiol 2000;111:S136-40.
15. Jenner P. The MPTP-treated primate as a model of motor complications in PD: primate model of motor complications. Neurology 2003;61:S4-11.
16. van Vliet SA, Vanwersch RA, Jongsma MJ, van der Gugten J, Olivier B, Philippens IH. Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects. Behav Pharmacol 2006;17:453-62. (Pubitemid 44325807)
17. Verhave PS, Vanwersch RA, van Helden HP, Smit AB, Philippens IH. Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease. Behav Brain Res 2009;200:214-9.
18. Pearce RK, Collins P, Jenner P, Emmett C, Marsden CD. Intraventricular infusion of basic fibroblast growth factor (bFGF) in the MPTP-treated common marmoset. Synapse 1996;23:192-200. (Pubitemid 26230566)
19. Iravani MM, Jackson MJ, Kuoppamaki M, Smith LA, Jenner P. 3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- treated primates. J Neurosci 2003;23:9107-15. (Pubitemid 37243811)
20. Rechtschaffen A, Kales A, eds. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects Los Angeles: Brain Information Service/Brain Research Institute, University of California, 1968.
21. Edgar DM, Dement WC, Fuller CA. Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation. J Neurosci 1993;13:1065-79. (Pubitemid 23067594)
22. Almirall H, Pigarev I, de la Calzada MD, Pigareva M, Herrero MT, Sagales T. Nocturnal sleep structure and temperature slope in MPTP treated monkeys. J Neural Transm 1999;106:1125-34. (Pubitemid 30009210)
23. Wolthuis OL, Groen B, Philippens IH. A simple automated test to measure exploratory and motor activity of marmosets. Pharmacol Biochem Behav 1994;47:879-81. (Pubitemid 24119896)
24. Philippens IH, Melchers BP, Roeling TA, Bruijnzeel PL. Behavioral test systems in marmoset monkeys. Behav Res Methods Instrum Comput 2000;32:173-9.
25. Stiasny-Kolster K, Doerr Y, Moller JC, et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005;128:126-37. (Pubitemid 40070527)
26. Marek K, Jennings D. Can we image premotor Parkinson disease? Neurology 2009;72:S21-6.
27. Tolosa E, Poewe W. Premotor Parkinson disease. Neurology 2009;72:S1.
28. Stephenson R, Siderowf A, Stern MB. Premotor Parkinson's disease: clinical features and detection strategies. Mov Disord 2009;24 Suppl 2:S665-70.
29. Monaca C, Laloux C, Jacquesson JM, et al. Vigilance states in a parkinsonian model, the MPTP mouse. Eur J Neurosci 2004;20:2474-8. (Pubitemid 39472409)
30. Yi PL, Tsai CH, Lu MK, Liu HJ, Chen YC, Chang FC. Interleukin-1beta mediates sleep alteration in rats with rotenone-induced parkinsonism. Sleep 2007;30:413-25.
31. Lima MM, Andersen ML, Reksidler AB, Vital MA, Tufik S. The role of the substantia nigra pars compacta in regulating sleep patterns in rats. PLoS ONE 2007;2:e513.
32. Pungor K, Papp M, Kekesi K, Juhasz G. A novel effect of MPTP: the selective suppression of paradoxical sleep in cats. Brain Res 1990;525:310-4. (Pubitemid 20257752)
33. Barraud Q, Lambrecq V, Forni C, et al. Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model. Exp Neurol 2009;219:574-82.
34. American Academy of Sleep Medicine. International classification of sleep disorders: Diagnostic and coding manual, 2nd ed. Westchester IL: American Academy of Sleep Medicine; 2005:148-52.
35. Mayer G, Kesper K, Ploch T, et al. Quantification of tonic and phasic muscle activity in REM sleep behavior disorder. J Clin Neurophysiol 2008;25:48-55. (Pubitemid 351321464)
36. Levey AI, Hersch SM, Rye DB, et al. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci U S A 1993;90:8861-5. (Pubitemid 23306410)
37. Dzirasa K, Ribeiro S, Costa R, et al. Dopaminergic control of sleep-wake states. J Neurosci 2006;26:10577-89. (Pubitemid 44564610)
38. Dahan L, Astier B, Vautrelle N, Urbain N, Kocsis B, Chouvet G. Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep. Neuropsychopharmacology 2007;32:1232-41. (Pubitemid 46788854)
39. Garcia-Borreguero D, Caminero AB, De La Llave Y, et al. . . Decreased phasic EMG activity during rapid eye movement sleep in treatment-naive Parkinson's disease: effects of treatment with levodopa and progression of illness. Mov Disord 2002;17:934-41. (Pubitemid 36040998)
40. Fantini ML, Gagnon JF, Filipini D, Montplaisir J. The effects of pramipexole in REM sleep behavior disorder. Neurology 2003;61:1418-20. (Pubitemid 37463382)
41. Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003;110:517-36. (Pubitemid 36543283)
42. Lai YY, Siegel JM. Muscle tone suppression and stepping produced by stimulation of midbrain and rostral pontine reticular formation. J Neurosci 1990;10:2727-34.